RLBGX | SBACX | RLBGX / SBACX | |
Total Expense Ratio | 0.25 | 1.78 | 14% |
Annual Report Gross Expense Ratio | 0.25 | 1.78 | 14% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 4.592 | 2.494 | 184% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 244B | 941M | 25,930% |
Annual Yield % from dividends | 2.23 | 0.63 | 356% |
Returns for 1 year | 5.63 | 7.84 | 72% |
Returns for 3 years | 33.78 | 37.40 | 90% |
Returns for 5 years | 40.35 | 35.63 | 113% |
Returns for 10 years | 60.87 | 50.25 | 121% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PCF | 6.37 | 0.01 | +0.16% |
High Income Securities Fund | |||
XIDE | 30.03 | -0.10 | -0.33% |
FT Vest U.S. Eq Buf & PrmIncETF-Dec | |||
BMEZ | 14.41 | -0.17 | -1.17% |
BlackRock Health Sciences Term Trust | |||
JPEM | 55.97 | -0.69 | -1.21% |
JPMorgan Diversified Return EMkts Eq ETF | |||
DFAU | 40.89 | -0.50 | -1.21% |
Dimensional US Core Equity Market ETF |